AC Immune SA (ACIU)
NASDAQ: ACIU · Real-Time Price · USD
3.050
+0.070 (2.35%)
At close: May 4, 2026, 4:00 PM EDT
3.020
-0.030 (-0.98%)
After-hours: May 4, 2026, 4:23 PM EDT

AC Immune Income Statement

Millions CHF. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
3.73.5727.3114.83.94-
Revenue Growth (YoY)
-86.92%-86.92%84.51%276.14%--
Gross Profit
3.73.5727.3114.83.94-
Selling, General & Admin
15.8316.0917.2615.3115.7917.91
Research & Development
52.2656.4462.5754.6160.3462.28
Other Operating Expenses
0.570.550.141.491.341.18
Total Operating Expenses
68.6673.0879.9771.477.4781.37
Operating Income
-64.96-69.51-52.66-56.6-73.53-81.37
Interest Income
1.411.873.21.040.076.49
Interest Expense
-0.2-0.19-0.13-0.18-0.36-0.58
Other Non-Operating Income (Expense)
-1.49-1.131.47-0.60.116.02
Total Non-Operating Income (Expense)
-0.280.554.530.27-0.1811.92
Pretax Income
-66.22-70.45-50.91-54.22-70.74-72.99
Provision for Income Taxes
--00.010.010
Net Income
-66.22-70.45-50.92-54.23-70.75-73
Net Income to Common
-66.22-70.45-50.92-54.23-70.75-73
Shares Outstanding (Basic)
100101100858475
Shares Outstanding (Diluted)
100101100858475
Shares Change (YoY)
0.11%1.06%17.71%1.36%11.48%4.24%
EPS (Basic)
-0.66-0.70-0.51-0.64-0.85-0.97
EPS (Diluted)
-0.66-0.70-0.51-0.64-0.85-0.97
Shares Outstanding
101.77101.74100.4199.283.6283.48
Free Cash Flow
--70.1665.27-61.21-74.81-68.32
Free Cash Flow Per Share
--0.700.65-0.72-0.90-0.91
Gross Margin
100.00%100.00%100.00%100.00%100.00%-
Operating Margin
-1754.73%-1945.31%-192.84%-382.38%-1868.69%-
Profit Margin
-1788.79%-1971.65%-186.44%-366.41%-1798.04%-
FCF Margin
--1963.67%238.99%-413.55%-1901.07%-
EBITDA
-64.96-67-50.5-54.38-71.17-78.97
EBITDA Margin
-1754.73%-1875.26%-184.92%-367.41%-1808.74%-
EBIT
-64.96-69.51-52.66-56.6-73.53-81.37
EBIT Margin
-1754.73%-1945.31%-192.84%-382.38%-1868.69%-
Effective Tax Rate
-0.00%-0.01%-0.02%-0.02%-0.00%
Updated Apr 30, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q